<SEC-DOCUMENT>0001213900-22-037700.txt : 20220707
<SEC-HEADER>0001213900-22-037700.hdr.sgml : 20220707
<ACCEPTANCE-DATETIME>20220706181547
ACCESSION NUMBER:		0001213900-22-037700
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220630
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220707
DATE AS OF CHANGE:		20220706

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CREATIVE REALITIES, INC.
		CENTRAL INDEX KEY:			0001356093
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				411967918
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33169
		FILM NUMBER:		221070049

	BUSINESS ADDRESS:	
		STREET 1:		13100 MAGISTERIAL DRIVE
		STREET 2:		SUITE 100
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40223
		BUSINESS PHONE:		502-791-8800

	MAIL ADDRESS:	
		STREET 1:		13100 MAGISTERIAL DRIVE
		STREET 2:		SUITE 100
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40223

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WIRELESS RONIN TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20060313
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea162551-8k_creative.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:CREX="http://cri.com/20220630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_CREX_cri.com_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20220630_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001356093 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityCentralIndexKey">0001356093</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="crex-20220630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-06-30to2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001356093</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-30</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001356093</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CREX:CommonStockParValue0.01PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-30</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001356093</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CREX:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-30</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 1pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">UNITED STATES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_908_edei--DocumentType_c20220630__20220630_zn5B2Q7leCKa"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase">Pursuant to
Section 13 or 15(</span>d<span style="text-transform: uppercase">) of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase">the Securities
Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (date of earliest event reported): <span id="xdx_90B_edei--DocumentPeriodEndDate_c20220630__20220630_zKwUZ2kHWVtl"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June
30, 2022</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20220630__20220630_zB0bDtwTqpD4"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityRegistrantName">CREATIVE REALITIES, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20220630__20220630_zF5V9i4A4ny3"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Minnesota</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20220630__20220630_zlVDtM0yVrEj"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityFileNumber">001-33169</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20220630__20220630_zA4KWlgSNHw6"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityTaxIdentificationNumber">41-1967918</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of<br />
incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer<br />
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20220630__20220630_zA8f5greVYE5"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityAddressAddressLine1">13100 Magisterial Drive</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20220630__20220630_znaxFHybNhTf"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressCityOrTown_c20220630__20220630_zHxteEPCCRO4"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityAddressCityOrTown">Louisville</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20220630__20220630_ztiwlqCcwtZ5"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityAddressStateOrProvince">KY</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressPostalZipCode_c20220630__20220630_z2sm1WepNFG6"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:EntityAddressPostalZipCode">40223</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90D_edei--CityAreaCode_c20220630__20220630_zpThOUoQG0gf"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:CityAreaCode">(502)</ix:nonNumeric></span> <span id="xdx_908_edei--LocalPhoneNumber_c20220630__20220630_zI96T7eVMAii"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" name="dei:LocalPhoneNumber">791-8800</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&#8217;s telephone number, including area
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Not applicable</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since last
report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90F_edei--WrittenCommunications_c20220630__20220630_zDhd0MIRyLxj"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90B_edei--SolicitingMaterial_c20220630__20220630_zJp8XPSWEX65"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20220630__20220630_z0O5P1v1Qm8i"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20220630__20220630_zLCGqgqdEMbk"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20220630__20220630_zfjFaMeAcPQb"><ix:nonNumeric contextRef="From2022-06-30to2022-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities registered pursuant to Section 12(b) of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--Security12bTitle_c20220630__20220630__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_zcs82HfN9sr9"><ix:nonNumeric contextRef="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember" name="dei:Security12bTitle">Common Stock, par value $0.01 per share</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20220630__20220630__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_zAy6Fls6RXUb"><ix:nonNumeric contextRef="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember" name="dei:TradingSymbol">CREX</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_903_edei--SecurityExchangeName_c20220630__20220630__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_zYnwa9iPhMUe"><ix:nonNumeric contextRef="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20220630__20220630__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zXkBtwwt867c"><ix:nonNumeric contextRef="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember" name="dei:Security12bTitle">Warrants to purchase Common Stock</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20220630__20220630__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zccWKAc1Er12"><ix:nonNumeric contextRef="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember" name="dei:TradingSymbol">CREXW</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_905_edei--SecurityExchangeName_c20220630__20220630__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zucusSbf6a"><ix:nonNumeric contextRef="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><b>Item
1.01 Entry into Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Effective
June 30, 2022, the Company amended the terms of the 5,194,495 warrants previously issued to its creditor, Slipstream Communications, LLC
(&#8220;Slipstream&#8221;), and the 8,566,505 warrants previously issued to an investor of the Company, Armistice Capital Master Fund
Ltd. (&#8220;Investor&#8221;). The amendments to such warrants removes the holder&#8217;s option to exercise such warrants on a cashless
basis utilizing the volume weighted average price (VWAP) of the Company&#8217;s common stock on the trading day immediately preceding
the date of a notice of cashless exercise in certain circumstances, and removes the condition to exercising such warrants that the Company&#8217;s
shareholders approve the exercise thereof (which has already been obtained). The amendments to the warrants also extend the term of such
warrants for an additional one year, such that 7,166,505 of the Investor&#8217;s warrants will expire on February 3, 2028, and Slipstream&#8217;s
5,194,495 warrants and the Investor&#8217;s remaining 1,400,000 warrants will expire on February 17, 2028. The foregoing amendments to
the warrants are intended to cause such warrants to be accounted for as equity instruments on the Company&#8217;s financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The foregoing description of the
amendments to the warrants are not complete descriptions thereof and are qualified in their entireties by reference to the full text of
such documents filed as Exhibits 10.1, 10.2, and 10.3 to this Current Report on Form 8-K, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>Item 3.02. Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The disclosures
set forth in Item 1.01 related to the issuance of the amended warrants are hereby incorporated by reference into this Item 3.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Based
in part upon the representations of Slipstream and the Investor, the offering and sales of the amended warrants are exempt from registration
under Section 4(a)(2) of the Securities Act. The issuance of the amended warrants by the Company will not be registered under the Securities
Act or any state securities laws and neither of the warrants, nor the Company common stock issuable pursuant thereto, may be offered or
sold in the United States absent registration with the SEC or an applicable exemption from the registration requirements. The offering
and issuance of such warrants did not involve a public offering and were made without general solicitation or general advertising.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Item 9.01 Financial Statements
and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
Number</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: left; vertical-align: bottom; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: bottom"><a href="ea162551ex10-1_creative.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lender Warrant dated June 30, 2022.</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: bottom"><a href="ea162551ex10-2_creative.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor Warrant dated June 30, 2022 (7,166,505 shares)</span></a></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: left; vertical-align: bottom"><a href="ea162551ex10-3_creative.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor Warrant dated June 30, 2022 (1,400,000 shares)</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Creative Realities, Inc.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July 6, 2022</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Will Logan</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Will Logan<br />
<i>Chief Financial Officer</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-variant: small-caps"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kVFLwzAQxz9Bv8NRfCxbWqZC37ToEDcp25i+nt3NhbW5ckmn+0h+S9N0wz1oCIRw/9/9LiSOk3jKj7omgbf7xQxW1LQ1OoIFbUnIVOQTxdNzDv5c0Ie2TtC4cD2DBXuGPHM9SifoCyF60JY2OajbsboZZxmoST5JoZzHUV8v2Gz1hozTWAOaDZTCrWhyKMehwwq/2HBzDKo1idVsckhHaih/Q6bSDF74gJ8sewuzWRFHSVhRPBXu2l7TWccNPNTUeJcd0N8dRqlCJn9F6V9mV1x2Uu3Qkn9Xw2bpuNrPqXkn8eFUZd57dxrizIBjaE8UDBgE7g/PRdcSZY11R2qk0pJkuUOhf0yXTRNoUeDQk3DVs9D6X7A9ffb9ABPmjUs= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea162551ex10-1_creative.htm
<DESCRIPTION>LENDER WARRANT DATED JUNE 30, 2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CREATIVE
REALITIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 5,194,495</FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: August 17, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: June 30, 2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Slipstream Communications, LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
August 17, 2022 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on February 17, 2028
(the &ldquo;<U>Termination Date</U>&rdquo;), but not thereafter, to subscribe for and purchase from Creative Realities, Inc., a Minnesota
corporation (the &ldquo;<U>Company</U>&rdquo;), up to 5,194,495 shares of the Company&rsquo;s common stock, par value $0.01 per share
(the &ldquo;<U>Common Stock</U>&rdquo;) (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). This Warrant was
issued pursuant to Section 1.9 of that certain Second Amended and Restated Loan and Security Agreement, dated as of February 17, 2022
(the &ldquo;<U>Credit Agreement</U>&rdquo;), by and between the Company, the Holder and other signatory thereto. This Warrant amends and
restates the terms of the Common Stock Purchase Warrant dated February 17, 2022 in its entirety.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&nbsp;<U>Definitions</U>.
Intentionally Omitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto, and delivered in accordance
with the notice requirements set forth in Section 5(h) (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2)
Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such
notice. &ldquo;<U>Business Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $1.41 subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. If after the Issue Date there is no effective registration statement registering, or the prospectus contained therein is
not available for the resale of the Warrant Shares, then this Warrant may also be exercised, in whole or in part, at such time by means
of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares determined according
to the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">Net Number =&nbsp;<U>(A
x B) - (A x C)</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 160pt; text-align: justify">B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">For purposes of
the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(A) = the total number of Warrant Shares
with respect to which this Warrant is then being exercised if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(B) = as applicable: (i) the VWAP on the
Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, (ii) the Bid Price of the shares of Common Stock on the principal Trading Market
as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise
is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until
two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP
on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is
both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(C) = the Exercise
Price then in effect for the applicable Warrant Shares at the time of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties hereto acknowledge and agree that in accordance with Section 3(a)(9) of the Securities
Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and for purposes of Rule 144 of the Securities
Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees
not to take any position contrary to this Section 2(c). Notwithstanding anything to the contrary, without limiting the rights of the Holder
to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein and the right of the Holder to exercise this Warrant
on a &ldquo;cashless exercise&rdquo; pursuant to this Section 2(c), in the event the Company does not have or maintain an effective registration
statement, there are no circumstances that would require the Company to make any cash payments or net cash settle the purchase warrants
to the holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&lsquo;&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the bid price of the shares of Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)
if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the
most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&rdquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&rdquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&rdquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&rdquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the daily volume weighted average price of the shares of Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&rdquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants and subject to receipt from the Holder by the Company and the Transfer Agent of
customary representations reasonably acceptable to the Company and the Transfer Agent in connection with such request), and otherwise
by physical delivery of a certificate (or an account statement reflecting unrestricted shares of Common Stock), registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in
the instance of a cashless exercise) is received by the Company by such date, and (ii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received
by the Company on or prior to the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and
not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the shares of Common Stock on the date
of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated
damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant
remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period,
expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the shares of Common Stock as in
effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause Computershare Limited, or the then current transfer agent of the Company (the &ldquo;<U>Transfer
Agent</U>&rdquo;) to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the
Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure solely caused by incorrect or
incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total
purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required
to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect
of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">v.&nbsp;<U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;Intentionally
Omitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on its shares of Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares of Common Stock, or (iv) issues by reclassification of
shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>[RESERVED</U>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to (but without duplication of) any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant immediately before the date on
which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Pro Rata
Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than cash)
or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date
as of which the record holders of Common Stock are to be determined for the participation in such Distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Fundamental Transaction</U>. If, at
any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger
or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license,
assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions,
(iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of more than 50% of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the shares of Common Stock or
any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares
of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) and in
connection with such transaction the Common Stock is converted into or exchanged for other securities, cash or property (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the securities, cash and other property
of the successor or acquiring corporation (or ultimate parent company thereof) or of the Company, if it is the surviving corporation,
as applicable (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of shares of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following
such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
Successor Entity shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days after, the
consummation of such Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the
holders of shares of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the
form of cash, stock or any combination thereof, or whether the holders of shares of Common Stock are given the choice to receive from
among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of shares
of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of shares of Common
Stock will be deemed to have received shares of common stock of the Successor Entity (which Successor Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;&lsquo;<U>Bloomberg</U>&rdquo;)
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained
from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the
public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation
shall be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will
be made by wire transfer of immediately available funds within five Business Days of the Holder&rsquo;s election (or, if later, on the
effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the
Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under
this Warrant and the Other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for the Alternate Consideration, and with an exercise price which applies
the exercise price hereunder to such Alternate Consideration (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such Alternate Consideration, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the shares
of Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the shares of Common Stock,
(C) the Company shall authorize the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase
any capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the shares of Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer
of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the shares of Common Stock are converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its
last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least five (5) calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or stock exchange is expected to become effective
or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled to exchange their
shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or stock exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice and provided further, that no notice shall be required if
the information is disseminated in a press release or document publicly filed with the Commission. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during
the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be
expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Voluntary
Adjustments by the Company</U>. The Company may, subject to the rules and regulations of the Trading Market, at any time during the term
of this Warrant, reduce the then current Exercise Price to any amount and extend the term of this Warrant for any period of time deemed
appropriate by the Board of Directors of the Company, with the prior written consent of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&nbsp;<U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant
except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Intentionally
Omitted.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No Rights
as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder
of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the shares of Common Stock may be listed. The Company covenants that all Warrant
Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights
represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid
and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction
and Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with Sections 11.6-11.8 of the Credit Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Credit Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provision in Section 11.5 of the Credit Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREATIVE REALITIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Will Logan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Will Logan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGED:</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SLIPSTREAM COMMUNICATIONS, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brian Friedman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Friedman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TO:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREATIVE REALITIES, INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744;&nbsp;in lawful money of the
United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744;&nbsp;if permitted the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) Accredited Investor. The
undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:______________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:______________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">13</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0in; margin-bottom: 0in; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea162551ex10-2_creative.htm
<DESCRIPTION>INVESTOR WARRANT DATED JUNE 30, 2022 (7,166,505 SHARES)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CREATIVE
REALITIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 7,166,505</FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: June 30, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: June 30, 2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
February 3, 2022 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on February 3, 2028
(the &ldquo;<U>Termination Date</U>&rdquo;), but not thereafter, to subscribe for and purchase from Creative Realities, Inc., a Minnesota
corporation (the &ldquo;<U>Company</U>&rdquo;), up to 7,166,505 shares of the Company&rsquo;s common stock, par value $0.01 per share
(the &ldquo;<U>Common Stock</U>&rdquo;) (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). This Warrant was
issued pursuant to Sections 2.1 and 2.2 of that certain Securities Purchase Agreement, dated as of February 3, 2022, by and between the
Company, the Holder and other purchasers signatory thereto (as may be amended, amended and restated, supplemented or otherwise modified
from time to time in accordance with its terms, the &ldquo;<U>Purchase Agreement</U>&rdquo;). This Warrant amends and restates the terms
of the Common Stock Purchase Warrant dated February 17, 2022 in its entirety.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&nbsp;<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto, and delivered in accordance
with the notice requirements set forth in Section 5(h) (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2)
Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such
notice. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time)
on the Trading Date prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase
Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial
Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of
the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.&nbsp;<B>The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</B>&nbsp;&ldquo;<U>Business Day</U>&rdquo; means any day other than Saturday,
Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for
wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $1.41 subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. If after the Issue Date there is no effective registration statement registering, or the prospectus contained therein is
not available for the resale of the Warrant Shares, then this Warrant may also be exercised, in whole or in part, at such time by means
of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares determined according
to the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">Net Number =&nbsp;<U>(A
x B) - (A x C)</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 160pt; text-align: justify">B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">For purposes of
the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(A) = the total number of Warrant Shares
with respect to which this Warrant is then being exercised if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(B) = as applicable: (i) the VWAP on the
Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, (ii) the Bid Price of the shares of Common Stock on the principal Trading Market
as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise
is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until
two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP
on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is
both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(C) = the Exercise
Price then in effect for the applicable Warrant Shares at the time of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties hereto acknowledge and agree that in accordance with Section 3(a)(9) of the Securities
Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and for purposes of Rule 144 of the Securities
Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees
not to take any position contrary to this Section 2(c). Notwithstanding anything to the contrary, without limiting the rights of the Holder
to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein and the right of the Holder to exercise this Warrant
on a &ldquo;cashless exercise&rdquo; pursuant to this Section 2(c), in the event the Company does not have or maintain an effective registration
statement, there are no circumstances that would require the Company to make any cash payments or net cash settle the purchase warrants
to the holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the bid price of the shares of Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)
if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the daily volume weighted average price of the shares of Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants and subject to receipt from the Holder by the Company and the Transfer Agent of
customary representations reasonably acceptable to the Company and the Transfer Agent in connection with such request), and otherwise
by physical delivery of a certificate (or an account statement reflecting unrestricted shares of Common Stock), registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in
the instance of a cashless exercise) is received by the Company by such date, and (ii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received
by the Company on or prior to the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and
not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the shares of Common Stock on the date
of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated
damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant
remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period,
expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the shares of Common Stock as in
effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause Computershare Limited, or the then current transfer agent of the Company (the &ldquo;<U>Transfer
Agent</U>&rdquo;) to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the
Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure solely caused by incorrect or
incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total
purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required
to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect
of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">v.&nbsp;<U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of
the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be
effective until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this
paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained
or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this
paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on its shares of Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares of Common Stock, or (iv) issues by reclassification of
shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>[RESERVED</U>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to (but without duplication of) any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,&nbsp;<U>however</U>,
to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Pro Rata
Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than cash)
or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,&nbsp;<U>however</U>,
to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Fundamental Transaction</U>. If, at
any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger
or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license,
assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions,
(iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of more than 50% of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the shares of Common Stock or
any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares
of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) and in
connection with such transaction the Common Stock is converted into or exchanged for other securities, cash or property (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the securities, cash and other property
of the successor or acquiring corporation (or ultimate parent company thereof) or of the Company, if it is the surviving corporation,
as applicable (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of shares of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following
such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
Successor Entity shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days after, the
consummation of such Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the
holders of shares of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the
form of cash, stock or any combination thereof, or whether the holders of shares of Common Stock are given the choice to receive from
among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of shares
of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of shares of Common
Stock will be deemed to have received shares of common stock of the Successor Entity (which Successor Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained
from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the
public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation
shall be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will
be made by wire transfer of immediately available funds within five Business Days of the Holder&rsquo;s election (or, if later, on the
effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the
Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under
this Warrant and the Other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for the Alternate Consideration, and with an exercise price which applies
the exercise price hereunder to such Alternate Consideration (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such Alternate Consideration, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the shares
of Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the shares of Common Stock,
(C) the Company shall authorize the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase
any capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the shares of Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer
of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the shares of Common Stock are converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its
last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least five (5) calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or stock exchange is expected to become effective
or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled to exchange their
shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or stock exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice and provided further, that no notice shall be required if
the information is disseminated in a press release or document publicly filed with the Commission. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during
the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be
expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Voluntary
Adjustments by the Company</U>. The Company may, subject to the rules and regulations of the Trading Market, at any time during the term
of this Warrant, reduce the then current Exercise Price to any amount and extend the term of this Warrant for any period of time deemed
appropriate by the Board of Directors of the Company, with the prior written consent of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&nbsp;<U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Article IV of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are
transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together
with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney
and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment,
the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this
Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall
not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case,
the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment
form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant
except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No Rights
as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder
of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the shares of Common Stock may be listed. The Company covenants that all Warrant
Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights
represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid
and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction
and Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with Section 5.9 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provision in Section 5.4 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREATIVE REALITIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">/s/ Will Logan</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>Will Logan</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGED:</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARMISTICE CAPITAL MASTER FUND LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Steven Boyd</P>
</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> Steven Boyd</P>
</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CIO of Armistice Capital, LLC, the Investment Manger</P>
</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TO:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREATIVE REALITIES, INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744;&nbsp;in lawful money of the
United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744;&nbsp;if permitted the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) Accredited Investor. The
undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:______________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:______________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">14</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ea162551ex10-3_creative.htm
<DESCRIPTION>INVESTOR WARRANT DATED JUNE 30, 2022 (1,400,000 SHARES)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CREATIVE
REALITIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 1,400,000</FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: August 17, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: June 30, 2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
August 16, 2022 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on February 17, 2028
(the &ldquo;<U>Termination Date</U>&rdquo;), but not thereafter, to subscribe for and purchase from Creative Realities, Inc., a Minnesota
corporation (the &ldquo;<U>Company</U>&rdquo;), up to 1,400,000 shares of the Company&rsquo;s common stock, par value $0.01 per share
(the &ldquo;<U>Common Stock</U>&rdquo;) (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). This Warrant amends
and restates the terms of the Common Stock Purchase Warrant dated February 17, 2022 in its entirety.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&nbsp;<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Securities Purchase Agreement, dated
as of February 3, 2022, by and between the Company, the Holder and other purchasers signatory thereto (as may be amended, amended and
restated, supplemented or otherwise modified from time to time in accordance with its terms, the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto, and delivered in accordance
with the notice requirements set forth in Section 5(h) (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2)
Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such
notice. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time)
on the Trading Date prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase
Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial
Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of
the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.&nbsp;<B>The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</B>&nbsp;&ldquo;<U>Business Day</U>&rdquo; means any day other than Saturday,
Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for
wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $1.41 subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. If after the Issue Date there is no effective registration statement registering, or the prospectus contained therein is
not available for the resale of the Warrant Shares, then this Warrant may also be exercised, in whole or in part, at such time by means
of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares determined according
to the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">Net Number =&nbsp;<U>(A
x B) - (A x C)</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 160pt; text-align: justify">B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">For purposes of
the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(A) = the total number of Warrant Shares
with respect to which this Warrant is then being exercised if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(B) = as applicable: (i) the VWAP on the
Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, (ii) the Bid Price of the shares of Common Stock on the principal Trading Market
as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise
is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until
two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP
on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is
both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(C) = the Exercise
Price then in effect for the applicable Warrant Shares at the time of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties hereto acknowledge and agree that in accordance with Section 3(a)(9) of the Securities
Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and for purposes of Rule 144 of the Securities
Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees
not to take any position contrary to this Section 2(c). Notwithstanding anything to the contrary, without limiting the rights of the Holder
to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein and the right of the Holder to exercise this Warrant
on a &ldquo;cashless exercise&rdquo; pursuant to this Section 2(c), in the event the Company does not have or maintain an effective registration
statement, there are no circumstances that would require the Company to make any cash payments or net cash settle the purchase warrants
to the holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the bid price of the shares of Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)
if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the daily volume weighted average price of the shares of Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants and subject to receipt from the Holder by the Company and the Transfer Agent of
customary representations reasonably acceptable to the Company and the Transfer Agent in connection with such request), and otherwise
by physical delivery of a certificate (or an account statement reflecting unrestricted shares of Common Stock), registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in
the instance of a cashless exercise) is received by the Company by such date, and (ii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received
by the Company on or prior to the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and
not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the shares of Common Stock on the date
of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated
damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant
remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period,
expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the shares of Common Stock as in
effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause Computershare Limited, or the then current transfer agent of the Company (the &ldquo;<U>Transfer
Agent</U>&rdquo;) to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the
Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure solely caused by incorrect or
incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total
purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required
to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect
of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&nbsp;<U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of
the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be
effective until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this
paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained
or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this
paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on its shares of Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares of Common Stock, or (iv) issues by reclassification of
shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>[RESERVED</U>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to (but without duplication of) any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,&nbsp;<U>however</U>,
to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Pro Rata
Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than cash)
or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,&nbsp;<U>however</U>,
to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Fundamental Transaction</U>. If, at
any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger
or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license,
assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions,
(iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of more than 50% of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the shares of Common Stock or
any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares
of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) and in
connection with such transaction the Common Stock is converted into or exchanged for other securities, cash or property (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the securities, cash and other property
of the successor or acquiring corporation (or ultimate parent company thereof) or of the Company, if it is the surviving corporation,
as applicable (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of shares of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following
such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
Successor Entity shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days after, the
consummation of such Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the
holders of shares of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the
form of cash, stock or any combination thereof, or whether the holders of shares of Common Stock are given the choice to receive from
among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of shares
of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of shares of Common
Stock will be deemed to have received shares of common stock of the Successor Entity (which Successor Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained
from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the
public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation
shall be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will
be made by wire transfer of immediately available funds within five Business Days of the Holder&rsquo;s election (or, if later, on the
effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the
Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under
this Warrant and the Other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for the Alternate Consideration, and with an exercise price which applies
the exercise price hereunder to such Alternate Consideration (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such Alternate Consideration, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the shares
of Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the shares of Common Stock,
(C) the Company shall authorize the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase
any capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the shares of Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer
of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the shares of Common Stock are converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its
last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least five (5) calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or stock exchange is expected to become effective
or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled to exchange their
shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or stock exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice and provided further, that no notice shall be required if
the information is disseminated in a press release or document publicly filed with the Commission. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during
the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be
expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Voluntary
Adjustments by the Company</U>. The Company may, subject to the rules and regulations of the Trading Market, at any time during the term
of this Warrant, reduce the then current Exercise Price to any amount and extend the term of this Warrant for any period of time deemed
appropriate by the Board of Directors of the Company, with the prior written consent of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&nbsp;<U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Article IV of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are
transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together
with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney
and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment,
the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this
Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall
not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case,
the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment
form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant
except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No Rights
as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder
of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the shares of Common Stock may be listed. The Company covenants that all Warrant
Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights
represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid
and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction
and Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with Section 5.9 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provision in Section 5.4 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREATIVE REALITIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Will Logan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Will Logan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGED:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARMISTICE CAPITAL MASTER FUND LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; font-size: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Steven Boyd</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Steven
                                Boyd</FONT></P><FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CIO of Armistice Capital, LLC, the Investment Manger</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TO:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CREATIVE REALITIES, INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744;&nbsp;in lawful money of the
United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744;&nbsp;if permitted the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) Accredited Investor. The
undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 49%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:______________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:______________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">15</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>crex-20220630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 86o5s7xRiXhun8uDb31cWaSO2aPty5BxeZkxsmx4Hdka3ycs2mQObS8ITKk24dMC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:CREX="http://cri.com/20220630" elementFormDefault="qualified" targetNamespace="http://cri.com/20220630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://cri.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="crex-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="crex-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="crex-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="CREX_CommonStockParValue0.01PerShareMember" name="CommonStockParValue0.01PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CREX_WarrantsToPurchaseCommonStockMember" name="WarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>crex-20220630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cri.com/role/Cover" xlink:href="crex-20220630.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cri.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="crex-20220630.xsd#CREX_CommonStockParValue0.01PerShareMember" xlink:label="loc_CREXCommonStockParValue0.01PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CREXCommonStockParValue0.01PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="crex-20220630.xsd#CREX_WarrantsToPurchaseCommonStockMember" xlink:label="loc_CREXWarrantsToPurchaseCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CREXWarrantsToPurchaseCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>crex-20220630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="crex-20220630.xsd#CREX_CommonStockParValue0.01PerShareMember" xlink:label="CREX_CommonStockParValue0.01PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CREX_CommonStockParValue0.01PerShareMember" xlink:to="CREX_CommonStockParValue0.01PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CREX_CommonStockParValue0.01PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.01 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="crex-20220630.xsd#CREX_WarrantsToPurchaseCommonStockMember" xlink:label="CREX_WarrantsToPurchaseCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CREX_WarrantsToPurchaseCommonStockMember" xlink:to="CREX_WarrantsToPurchaseCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CREX_WarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Warrants to purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>crex-20220630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cri.com/role/Cover" xlink:href="crex-20220630.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cri.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="crex-20220630.xsd#CREX_CommonStockParValue0.01PerShareMember" xlink:label="loc_CREXCommonStockParValue0.01PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CREXCommonStockParValue0.01PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="crex-20220630.xsd#CREX_WarrantsToPurchaseCommonStockMember" xlink:label="loc_CREXWarrantsToPurchaseCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CREXWarrantsToPurchaseCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140672409647600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CREATIVE REALITIES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001356093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1967918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">13100 Magisterial Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">791-8800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CREX_CommonStockParValue0.01PerShareMember', window );">Common Stock, par value $0.01 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CREX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CREX_WarrantsToPurchaseCommonStockMember', window );">Warrants to purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CREXW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CREX_CommonStockParValue0.01PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CREX_CommonStockParValue0.01PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CREX_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CREX_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>ea162551-8k_creative_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CREX="http://cri.com/20220630"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="crex-20220630.xsd" xlink:type="simple"/>
    <context id="From2022-06-30to2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356093</identifier>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356093</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CREX:CommonStockParValue0.01PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356093</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CREX:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-06-30to2022-06-30">0001356093</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-06-30to2022-06-30">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-06-30to2022-06-30">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-06-30to2022-06-30">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-06-30to2022-06-30">CREATIVE REALITIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-06-30to2022-06-30">MN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-06-30to2022-06-30">001-33169</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-06-30to2022-06-30">41-1967918</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-06-30to2022-06-30">13100 Magisterial Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-06-30to2022-06-30">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-06-30to2022-06-30">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-06-30to2022-06-30">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-06-30to2022-06-30">40223</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-06-30to2022-06-30">(502)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-06-30to2022-06-30">791-8800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-06-30to2022-06-30">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-06-30to2022-06-30">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-06-30to2022-06-30">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-06-30to2022-06-30">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-06-30to2022-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember">CREX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-06-302022-06-30_custom_CommonStockParValue0.01PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember">Warrants to purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember">CREXW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-06-302022-06-30_custom_WarrantsToPurchaseCommonStockMember">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #UD>94!P2A(J0$  #"$P  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)V8:W/J-A"&_XK&[73.F4F"92Z!%)@AA)S27 X-]*3M-V$+T,2V7$F&Y-]W
M98A-4K,F^0*V\;X\WEV_*[N[D>I)KS@WY#D*8]US5L8D%[6:]E<\8OI,)CR&
M7Q921<S KEK6=*(X"[*@**QYKMNJ14S$3K^;'9NH?E>F)A0QGRBBTRABZN62
MAW+3<ZCS>N!!+%?&'JCUNPE;\BDW?R83!7NU7"40$8^UD#%1?-%S!O3BTNO8
M@.R,'X)O]-XVL9<RE_+)[HR#GN-:(AYRWU@)!E]K/N1A:)6 X]^=J)/_IPW<
MWWY5O\XN'BYFSC0?RO!1!&;5<]H."?B"I:%YD)O?^.Z"FE;/EZ'./LEF>VZC
MX1 _U49&NV @B$2\_6;/NT3L![@' KQ=@)=Q;_\HH[QBAO6[2FZ(LF>#FMW(
M+C6+!C@1VZI,C8)?!<29_E"NN>K6#$C9 S5_%W:Y#?,.A/V>QF>D[IX0S_6\
MM^$U(,@QO!S#R_3J!_2NI)]"K0V9O22\# </;Y_>(!#U'**.J@R (,@HKD.V
M+*/ XQ<LU!SA:.0<C>.2,>%*R(",XH! <4OS@BOE9:JJ4S-':Z*"H]@(\T*N
M1<C)?1K-RWL'UW!=>EJOTU8'X6GE/*UC>![X4FBC&.3LGD6EB<)UA@^CP6S\
M8T3@^W8\&X^F)V1\/SQ#$,]SQ/-C$(=04,5",HX#_DQN^$L9)*[D0N;JS9;;
MJ2-8[1RK?0S6C#V3<0!L8B%\EAGEX;KBB@UZ2CNM\PYM(WB='*]S#-XX]J5*
MI,K(3LC4P&U I")#F4(Z(:LR**TV+GYWCQ!2M[!.]QC&01 HKO7)ZP:YA?/(
M][@4K$*2UJGKDCMFVQEN?NB7*P53"\/=<WKZ>=S91I;BXI+35$ ] !D#+&8
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M7YY2/%3SLWU8C X/=_R/]&'%$/K8U;_E+>:*AT^$(SH0%[ =^(BA%"/%PT?
M!UH0%SK<@K6]-S+V[=8=LQ:L2<@7H.2>G4-OJ^T+H^V.D4GVDF8NC9%1MKGB
M#.:(/0%^7TAI7G?L>Y_\M5W_/U!+ P04    " #UD>94X/0ZB:H"   P#
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M1AS!&  '#$G3_CUX]SY*QO=4<OF/L/D)4$L#!!0    ( /61YE27BKL<P
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MCEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0    ( /61YE0D'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ]9'F5&#GM-CO    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M]9'F5)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " #UD>94!P2A(J0$  #"$P  &
M    @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M]9'F5.#T.HFJ @  , P   T              ( !Z P  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " #UD>94EXJ[',     3 @  "P              @ &]
M#P  7W)E;',O+G)E;'-02P$"% ,4    " #UD>94JL0B%C,!   B @  #P
M            @ &F$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ]9'F
M5"0>FZ*M    ^ $  !H              ( !!A(  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ ]9'F5&60>9(9 0  SP,  !,
M         ( !ZQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  -10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea162551-8k_creative.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cri.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea162551-8k_creative.htm">ea162551-8k_creative.htm</File>
    <File>crex-20220630.xsd</File>
    <File>crex-20220630_def.xml</File>
    <File>crex-20220630_lab.xml</File>
    <File>crex-20220630_pre.xml</File>
    <File>ea162551ex10-1_creative.htm</File>
    <File>ea162551ex10-2_creative.htm</File>
    <File>ea162551ex10-3_creative.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea162551-8k_creative.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "crex-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea162551-8k_creative.htm"
     ]
    },
    "labelLink": {
     "local": [
      "crex-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "crex-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "crex-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "CREX",
   "nsuri": "http://cri.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea162551-8k_creative.htm",
      "contextRef": "From2022-06-30to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://cri.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea162551-8k_creative.htm",
      "contextRef": "From2022-06-30to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "CREX_CommonStockParValue0.01PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.01 per share"
       }
      }
     },
     "localname": "CommonStockParValue0.01PerShareMember",
     "nsuri": "http://cri.com/20220630",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "CREX_WarrantsToPurchaseCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase Common Stock"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockMember",
     "nsuri": "http://cri.com/20220630",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cri.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-22-037700-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-22-037700-xbrl.zip
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M;(Q5:<G[U; .@_Z_0;7\\NQQ^"]02P,$%     @ ]9'F5(;%GB'T"   7V@
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M8U!V1XEMPFPBR J)[90$U0/+/K8%PELI@\H[RF83:K=H,PYU$&1.DM6HU08
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MHUJF&WG+A+<6:($!,&_0"*<KAR\W3R\62'8UEKIP@&Z#!7;2D/YGCK?-#H/
M+#5)Y@0L1 )P ,8WVH,*VJ +CM+D:[7$(C\KBZF98,H6@E25:K0CM<B#OCA-
MD_.O>2B]+.=PC=8>H NJ[30+GD0S2H(KRE'IO#\':X'6^VQ!J9UFOA\1NQ?1
M6@7;B> !QN;!D-R=DS62KUH5M,">^G& QKG=BOOTPL[X!:KR.E+Q7TS1;$MO
M7)24:X%-E?1!=QR_BDH^;=G#X<?M#9YC819OW.*-^J@;NB^?7%46;[17QT4!
M6I9+O3_X>P'JYN_U=^EQ\\/\B1=]Y&]02P,$%     @ ]9'F5)L^QM?I"P
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M[$F1"D,RSA%)E8<[.AAJ*&W3 UC5N=%D7A%C]@:RDLF1TKN'Y)R&O1 I=6X
MT6R:\<A%'L)1=]:%AE"[!.,B2@(<9UXNQ#;]YY4.K6U 0+LZ) VA5Z! [D!8
MLH""&17B%)C_$,S[X5)1NH&E8=6,2BGS$!3=6Q<F4N\$DNF6\YIK>,2!I;8P
MZ3);< +IO "EPUSCV:),7@/%T0AT3M,H?9:K%*ZWAJ>*S!);;$#F"B;T_5ZP
M )C2&<AD2.I0)G32\L6O!#252T/ ZN@RNP283=8IJ&L\(L%H#*!AKU4K=9P0
M,14]$\?Q)0W)[G?R#-:KH;/+!&"S#H4F\H@*LS, BUR,E!H)N1,P;GFTQOQY
M%@4=0T53:!<-R&B=#5WE$1R -8".7(UFEU.7(\D<[RY# 6JTC+)5=AV4@'J[
ML'38KC,#B#U"I]TA0) (0O4HER!=TH#Q#:L\[C!E6]$!/D]9",]0.J+L0M6K
M"G6T6D,\ JR/3P"S6NBK[)D4Q.3J:%4 DB4X(>XL#,6)2O)_KB)*QF#]C5J[
M=+78K3-E$'I$$NP.X"=7OBH^(!F#;J@OT$P.J.K$/323OM!,O(9F\A)HYD_,
M$VA.#JCJB7MH3OI"<^(U-"<O@D8TO-.^9BH^WO Y>S(]G TJG2#3M&H$9B_S
M#Y>&MRY89("<S\@0EYBHB=4-O^7L,:(!/&6&Y$Z  4P;J=&T_J%C-MC%3SDA
M+N*<]C79I+SS2U+(W/0R=9/F+B;3^ =)W5AGYY*I72)QRY(4Q_^--JT7XF:Q
M$SR,AHV0U)3^H6*RUP5,%H-$D(L+ZQQ7^8.&<2F9MM_:K\TF6^5/S-6=7D!@
M<M1,5)'=/<E$MIM9,LH)!GJ$^FYKC6PP5;9Q99\?3=PTU&AA];T6&A=?9)DS
M+[Z]9Q1^0* IL=72D+FBM?7]7K0X8$IO=25#2N?H;KS,VY68N^_*/FLCNVZG
M',B+'5ZTKNZF,4P7^RVWYF<>I>+(,L_,EN:_\IB>&P1TMEJYU6;1XD:1%ZW?
MYJR1!RC3HKK8,A8S%D=!E$9T]4%<?/((FVIE$MD" C98T-!4>($":*N1R:44
MHD)I&8);KI)7$=$0:A&@3-?(;Y9+XVC?)K8%1;?A @Y8Z04DG?9T6$3 ,*A$
MH"P$J1BWV%PFR9;P@^ QA#A""#0/@-30^X@39+(3JBS0)5LS$FS%^/@\GBSF
M4=I(0F>66!N3 '/EB*3M]X(-P)3.@MHG,ZF.)_]8_(B**,O-?\WF',N4_+/G
M]8+%0/8IH\H6!"T6"PX,$B]0@'WI-%PSE$M1IG61G:IFUE =;;\M (RVBJ:O
M[?2BT4V.&E_^6EL[ZO+/=\&],$6 !0EFF>VNWV12[_ZK&B\0:#'6N"C)I:C0
MNEB0L!^R5MV3@)6S2<"J8Q*P\G$2L.H["5@YFP04A\U2A(A^Z6811RL,)"=L
M5=N&HL6RSH=!ZA4JL#^PSRA#T#[&=D9+E>),OO2(K]7Q+\0'0RT!G;6<EFTV
MRZ26)I$7C+0Y:Z2US)+.5<1(JFUSL0VCE(29F8N(8AI$."[3(YKNB'>'6*.E
MI_D2G Z]'PSU,]G *0LK<AF6@?M4E[9OI6</8'PF<?P[94]T1G#"* FS>RFF
M7XK:]7:?F.FP77]H!A![@5,?A\"C,S)H^""C4!&6WPES0M(G%F]IBKE:2\Y-
M/1.@LTL.8+-.C";RB!2S,X"04HPRM9L%VEGVB'*2E;W-$:P@)+>\7+O5M+9J
MVZCUB)E6@] :[CSGQWYNG$4Y6F*9$HZ#-'HD[W&*<V]@?2&Y[465;:;UU90F
MK4<(M1H$UT^6,3)5#"Z8<I8RAD_%5&O%6IX2UU3V$\<T+#9SQY02C_ P^6K)
M(,-1H77"PFR-X_C=-HDH2>"!2%/99<%HL<Y"3>(1"R9?  M*B@JM$Q;.UX2O
MQ/#V&V=/Z7V>GQ6L&Z"VRT:KY3HC1JE'K+3Y Y@I0E 64Z34=0//;I]0/,NR
M"-?4(+6,#6A68Z:A\PD8R%R#EI@$\G[+-4O1G*&/"4'I/4'G^<M]JYG@LW)<
MO6DD".2"B&Q63D/,30BUB:V_=00TW'CW2$/I!4B=]N#WD)01J BQ3,V-8)A7
MK^.4"?DN/7"U0W>(+8+ZFB\XZM)[05-/DSI3*JQ^<:T"U7L1768SJB:WAZ=X
M-9'EF;'!H#8QKBB\8 2T!4V+J^\*<),[;[N(H^ B9AB^RU+36,Z8U[2G)<O;
M"SPBH.D*2I&GA$@IG;3_.TP?^':3!L^WG 6$R*>LDK*WZKK_UC/:+C,'5:E.
M4Z]0CS@[Q"] X+X(5"GC567$<GDSK_+J\IE\JWURLTT3.8(*8_!=\-8@RS\O
M]*B ]B-#2X1'Z/6P"?W@4'FC_"N4!:-*M*/KLV2?!9"$[Y[OR))PN>Y@3G;I
M.W&@AY8KC!ZQMJ_>>E='OYCK#/0"PD/=0I=Z":H6@!;R&;&\"/1%%H)4*:;W
MEU<W78E/8G.Q2?RUP D16_X/4$L#!!0    ( /61YE3/CK2[.0@  /EB   5
M    8W)E>"TR,#(R,#8S,%]P<F4N>&ULU9W?<]HX$,??;^;^!Q_W3("D[5W2
MY#H)33I,TR87TA]W+QUA"]!$2(PD)_#?GV0P 6S)R_7*^OJ0$+.2]OM96=;:
MDGOZ9C;AT2-5FDEQUN@<M!L1%;%,F!B=-3[UF^?];J_7B+0A(B%<"GK6$++Q
MYH^??XKLO]-?FLWHBE&>G$1O9=SLB:%\'7TD$WH2O:."*F*D>AU])CQU1^05
MXU1%73F9<FJH_6+1\$GT\J#S@D3-)J#>SU0D4GVZZZWJ'1LSU2>MUM/3TX&0
MC^1)J@=]$,L)K,*^(2;5J]K:L_;RWZ+X*6?BX<3]&!!-(\M+Z).99F<-U^ZR
MV:>C ZE&K<-VN]/Z^N&Z'X_IA#29<-QBVLA+N5K*RG6.CX];V;>Y:<%R-E \
M;^.HE;NSJME^RP+V:YYH=J(S]ZYE3$P6]LIF(J^%^ZN9FS7=H6;GL'G4.9CI
MI)'#SP@JR>D='4;NMXW>JM58,1>KECO>ZDK;%ZV368FQHL.S1JSHS%9\>-A^
M==1VU?ZZ863F4]LG-7-=JA&U-IJ<*JJI,)G*:WM@HPB=&=N3:))7Y-H'.&68
M<7;++M*)FJX_I1/;C/VXL%SZD'O!9;S1,'?<Y9;*O ]G=#6-#T;RL950UG+*
MW8<,02;?_O$M:^A\H(TBL<EKXF1 >5;_-VNS9=+Z;J^&1 ^RP*>Z.2)DNG"-
M<J/S(\\^+@]\<^<6=7#NR<#%I^#HTG#;;MO;]4B>JTW/B8KSBNW'C3 6^^O2
MHC4ERM;7C,>,KWK 4,F)#]^R01GT6JJ$*CN*MMOHO&UWISW[40.8K]DB<_=P
M#<-?<W\9@,,:!*#+B=8WP[Z1\</YC$'B4"SR?PQ'4<7JM, *RKI+;^6$,.&/
M1IEMS<+@ZUI;$2E3L@S%OXU$R;7X[O*KO1I-)E)D#=T2E<VCV@?MSBU5_;%5
M]H%.!L\7T#7DKC"P;%4(5F?^#X+O[T(Y]1W$%/K+?QF,+T0I(HR^E[>IBL=V
M6K;F53 4H)+ 0!SA!F('"-\;AAUG;OEL\=[66#YQV[0 \OY1N/T3BAQWP6,4
MK.>V_<3Y<,7)J)SKE@D0; >5;*DL++1OJ;9YT=0!JB"\88D]=.\&ND0DT@AQ
M1T?,I1_.E96&\)#A*8(]9N\TB 1E(X7B7(B4\#LZE:HB IN60/ O:@&^3"02
M[S]3H@Q5? Y!7C &4G]9"^H>J5BS$CMKTLR!@I O6@/1OZH%>I]8)/;],>7<
MW1LG M3OR^R!_'^K!7^_X!I$X/+130:L&G@0UHH X_![[>)0D(T4"ILR,YE8
M&0H0A((Q$/]Q+?![I**"OQ0)%/O*%)Q0U8CZEDXDYE=,QX0O/+JRQ\IN%J^Y
M7F(.98^;S5;J1>7_%R4*3'_-&,H>-\&MT+IG\MU4J0UG@@..WQK*'C>UK5*[
M9_B7PC S=VLQ/J:>V\'6K&@%A8V;SOK4H4#.;V8(X]::A$!O6T)AXV:Q(94H
MP+O6845X3R1T]I[.0\0+IE#DN-EK4"<*\UO%)D3-^RRN'D^*ME#JN#EK6"D*
M]GLRZR76;39DBX5<U?2]1:!!P$U80;I18M$3L513N7;7NBM3>X;.NS()#OL5
M!:%QP<UD=V" $IWS)+'<]/*74]()Q:34'/P4JP:1".BM"?_#W?@?POGC9KB5
M>FO"_V@W_D=P_KA9;J5>3/Y=^_%&W<LGS^-SKS&4/6Z66Z$5DWSF_XVZ5?*1
M+5;!5^$OE(#&H [);U@UZBFPF!% ^G]N"05?AT2X7"4F\%NI#>%_LVG51+3<
M'@J_#BEQ2/&^;V\N.H"[+^);*[5E @6-FP67ZMHW6Q=J18F_0V]:0,GBIK9E
MJO8,]EJZAS)C*8*WA8M64,"X.:I/W;X'9[?K3'M'A;6OP8OV<(?>;3U[YOE%
M,6,]<*N[4[&\'^1Y@.<QA7+&32R#.O?,O"\YBYEA8O3!>JX8X>7 R^R@M''3
M2+_"/:.^5=G&!6JG[]F*-;=C5=T,A[[1.60/18^;158KQ@U!3^N4JET#45(*
M&@[<A!*J?M]#$(U3.R+..X>#>[<AVS, %:R@T'&329^Z/4/^*.\5<6^"Z,\G
M \G].VM*#:&H<5/'@,8]T][PHYSSE@F4,&[.6*H+:;BXG,5C(D;4OQBCW!)*
M&C>'#*E$&Y]'H/%YM./XC)M+^M0A05ZLG;?GV,V LQ'Q[\\+%@#O5:H%^H#F
M?6^/S+9-N1<*J4GFQY7]4,[?8PHEC[P5-:1SW\S3A!F:+%RZ8H*(V.9H*QF>
M&P#5I:"10-ZK"E2/\MSA"^7\O9!/HD^)EH(FBY0A].C!6P0:CCH\]ZS0C1*+
MSY*G%I?*5L,JSUGA,86RK\/S3H].G 6HB[7>J^O3XNUR(?2^$M (U.'!9U@U
MTI(\0]V[N]@C?4L,67H8"H2O!#00=7@(&E:-MM% =:V"D0P_^=\RA&*OP\+@
M4HTHM/L3POE%JJW+.CCL;!E":==A!7"I1A3:EQ.J1G:\>Z?DDQDO]]"&J'L*
M0.G789UO4#-.%&;/6_D7NPJ#(2BQ!K\RH@[\O6JQWHX2QVY=R.*R+Q*B//A#
M]M  U&,#JU_QGD-P8\94K<^Z,F><^Z$U'-6EH.' 382AZG$NQ&MO50A>AS?L
MH.#KD/*6*<39@)8..(NON"3!^?V&&11T'?+;$GTHG"^(>%#IU,3S6R5C2MUS
M';TZ_P 9%K ":&SJD/GNQ 3GCL3SFR^SMY#JF]1D[_.W_@7O2P3+06-4AZ08
M0@!I[J2?=\W1Y&)^1X=4N<46]W1F+FQ##^&I%* X-%#U>"<4F$=)O$Y;!8&V
MR0?[[?(;]\/]/P7VR#]02P,$%     @ ]9'F5*_3,;HW%P  G(D  !@   !E
M83$V,C4U,2TX:U]C<F5A=&EV92YH=&WM/?M7XLC2OWN._T-?[K?WZ%D>27@H
MZ' /\IAA1M$!U-GYQ=-)&L@8$NP$ ?_ZKZJ30("@Z(*/NW/W[@I)=W5UO;JZ
MJKHY_N^X;Y)[QAW#MC[%Y*04(\S2;-VPNI]B0[>3.(S]M[B[<]QSH1VTM9Q/
ML9[K#@JIU&@T2H[229MW4W(^GT^-L4W,:U081[93)$E._3@[;6D]UJ<)PW)<
M:FELVLDTK-O5\/'MM*G*36.N*3X)!DFGED##6WW6(=PXE_)>SC5U(YMFO:9N
MT-1P[(PB'SR&A]=BVF&\JJV,.,,,V8^3YNFLN1O=?M8TY7)J.1V;]ZD+/$1(
MV82D))1<"$C"8=H<(/B>[-KW3\(Y3*3E ,X2<^9GBJ]5ZDPIKK,%<@=CP@OH
MH2A!0\XZ*\'F4O V:#AT$EU*!]/&'>JHHJ'_8@XJ/..VR9S(UN+-7'/=Y0EW
M,F!.-"KP.H6OL8^4D.2$,B6+9@\MET^BY^J_G!O*X>XR4O!PKE&Y6?TQ;:5Q
M(ZG9?=% RJ6EF-!(1G7X2_!_QZ[AFJQXG/+^PML^<RG![@EV-S3N/\7*MN4R
MRTVT818QHGG?/L5<-G93GN*FL%_*!WO\KT2"U QFZ@728NX1:= ^*Y"Q/CXB
M]8KX<",I)S>7K3^4RN=2Z0+^('HDD5BW=SI[@[.\\6=W$\SN&2 RTK372[IG
ME1L&T@BHP_^K%A!O4@:J<&K6+9V-O[')C006*YW-2?GT<^#F0W!+?6;I\*];
M,VGWID--AST#5 Y)7+F1;WQ#XL&$1\^!H=RT>I0SYT:Y$7;3 ^*(9\^!4T%<
M+GQ8Z2645@)7;7U"''=BLD^Q#DA>@<C2P"5MHP]-&FQ$FG:?6G'O01P0X$9'
MR+ANW ?]=,,9F'12()9M,?'2&!=06!E'+1#?#%UGEM )_ H-&\,^P-(\<1^[
M3;0T-6[W45824BZ1EEQ[]CE&+)@U#,6,0J0TQ(HS<3A.S0VQF5'G9"56%,(2
M.5!J;KHX+MA)QF'I9H[7 LUQP1'K+"! Q.)9Z E;JW$V3@3JDAP[>LQ_C1;N
M4\PQ^@.3>?; 'VH>N#><8P]Y,!HT$[PO^%,FAO[HE .[%71C@MK3I]/GAHYO
M.@;C1$R%12YBY?JW><XL=IX-EXH<SQ]M /2U]64LP)/@;H6ZK#B;0@!I]FZI
M&[!R1:?@S2):<P@$#WV2KDOGV:<;;>BX8%?+=K]O6RW7UFXO*+^BYI!)24F^
M8%QH\AGKJXR_&4MF5&9=E/S0"_^5#LB,!Z:A&:Z'*]'!3EB>Q^HO_866"P3%
M_F63.LYY1TRW-#:<6!$7F<):1#A.18X7QC45C>P_4K"N*0>?T77:]@68@A[X
M?B$J_S/$:@T2_!:JPM R/(D")V%)(OJ,.D/.BKXW48 V ;#@U?P0"&T%?,\U
M63F$3P31Z,5CS%R@I7' 70%17*8M]A7+-W5MOBR)SZ#!(HY14$.#5IAE]PWK
MJ6&?ILOBN%& @_=S5%@BJ.]/A+P'SYD)/+GC%/2'O_C/\6#!:WS*:3PB?<J[
MAE4@X&/\Y]]R3CHZ3@V*D;">]$#G@$W!A!SEYM!DB0O:%?Y\V%?U^B5<>P!]
M!VX **':+MA-_]G(T-T>XB']$9OKK=H<2.'U/C&I=DL40-6Q34,_(O[+ )+W
M7IZ]Q\DE'..!"6K-B(!$]?\;FD%J;@H;(-,&:7Y$T) DJ&ETX:L&1A"7D\M&
MO5VMD%:[U*ZVMCA.JUJ^;-;;]6J+E!H54OU1_E)J?*Z2\OG96;W5JI\WMCCX
ML3.@5@!5-)@&9PID. ##JV&@I7A-G9YA=5W;BN_N5)+E)%&D;"9_G,+^Q2TB
MN'4V'ZO%VGGSC'B40+.+.]"\="@VUHE$Q=:&N%9B-.-&F\8 9M& !RM[HGP_
M,%GY&P5P?W=C%AXO5CQ,?%O<E4UIKGYHNH/0-ZN--FE6+\Z;[8\\DW5U"/PV
M9P@N'''MW9T6TS#X2>0TL3F1LWL^6_5UH>T3N[-]]5L7&[?' *(VY(9K,&=W
MISH&%]4"8U_27$"4R/ETYOU@&XC$MO%!9Q9GWV0#F[MD3_>_,PJ."G-<PNZA
M)>'B-=/W"TM6Z&3!"ET(3[CJ^<G1YNC;Z/*G<OOE^LHU7VR.O.#\IY@Q=@N(
M-.PSW)Y.)Q/ G%E1YFH.L5CQZ]!BNSMI*4X0[$H3]H&57BTN\BKG\\H+Z#59
MUW!0_%P,<$:SZD12*^ZH?3>H9#:P<D2-*S:/I7;]J@J&MG0JW(PXJ3?*R;=9
M5O:J8PH6 9%&1>!39 EUB#-@&NZM=6( 75V'@ T!O>#[KR<H+E5-!B]-$ZBA
MB=0DT!B_#ZBN!]_GD4"?N Q@56[$R1=FWC/7T"@@ *8GX6,1<L&GGK5FFR8=
M.. _!Y^\;=ZQRX,1[AE'6&: -7CJP5;PV-47W/C 4U<]3SV9G?GJ_O!IY8\U
M#*=P[#NT;YB3PE/4#6\")-P%1.A%;4XOZI9F<[!W(O<G@AYE+W-5MO45:E++
M7N6-3"EC3=*;L&B8HL3XA,L&W+Y'49PW:6O@&2N>&98%6TN7/JI'_D=77V::
MSY)5' GD,JKK.^>W/,?OFF$RH(W*>#1SS:N*>R9-KGCUU\9LX&Q,C.')B71:
MSN5_,^IQQ6S3<=V/;FI"Z!_C6BGS[=KLMAI?1KF-<6T% K%B1D[(^=Q!7CY<
MDX?P'_XR4[I='NP).X(.OPT.,R>_P%]V=,/;"8 [KW*1"C/"IF?_4>%\KD1N
M>7X8DC8<#&P3U$'B<?!#3:'>;)%J?V#:$\8#ALR+)6G8R?UH<4L)_Z'XVU/Y
MNYY*)O_V*U=)USES'/_/J6$Q>84Q/.QDNYQ=_57-;LP81@P>*\II8 LYH^@T
M W1JD@HW[I?R]KYLQI=VD_DGYJ>L"'#1<>W+1&WTVITMSD^)%5M# \PCS''M
M&9U$S:@,'\]YVQY9T?/Y,G99]:)<;IYO;MNU-'2L>&H/#>?>,,WU&52*FHY8
M-,[Y!3BKL#*L\)%=8V3>E;61^W/C,K@P?JSX[:_W[$N]C>DXC.+<A0W;#/.G
M,5B]MU&<OGS-!HW:Y\TY4E&C@Q<%/99JB3Z: ^5/#6,' P[2: S "+(QTX8N
M&$)X#(LT<SZ4PP$,(LBAMW<I7B5*5O$5!2UEB3.Z6C4&[=[YI?W]L]3=Q+(3
M'@^HGI64_17*L#(5=&J#^%_T;.O1#6T]GVL?L*NSDF%L .W%,6-%V <E#@]7
MKI';#N#-XHO_^?>A(A\<.=#.9 -$D5@"QS@!S32'Z(02"B3?W=$\^?ZXX=Z&
M[1(ZP*H:U,9MTK=F<^"G'R'E(FX%7ZEG]X"R'>)E5L \X6I,3.JXNSM>"N%#
MDOC7T(&]U216+/<8+.F820)*<QOL.VZ657M,5&;:(YPZOD0"D</$-](Q3) P
MV"X[(&\NLW2@B6L#6?I#TZ46LX>..2$.[-F<SD1T]7H06X61J;_I%B]"<>@A
MP %Z6Y/@70>V//8(^V&XT,#-K5/8)AW^%S9Z/G IJ60-:\4\5Z^A+=:U&;FL
MD]:DK]IFW$&TG57.V(JHUC4W7) *#$D,+7_K[D2;[$I/E\[JS<GI^.4QR'#*
M3+5MDU%+%%6'C7DD2LCP_$$F<[32H*_IRZQ!V.<Z)S["0(0PQF0PRV2+TB22
M4;*^XLPG@D7Z=T\^(.5:DRAI*0D-7]'/^:U2FU&I8)?=LD59*1#HC'H!B&A]
M^CHX_''1NJ[^R+U\,[J./BWC\YZ5:88MR*L?OUG2)#E#$[(24J:Y2HJI*F6D
MI-?RMS9]6&VZX**$&P^[B((O]&#X>:>S:F,AG6<OY'OY>__PY1N+=;1J-5[O
M6;L ZX060OO)-4O.Z EE3]U?3]>\MK^U[<-I6RU:V^J.,V3\29T[+7^^Z][I
MU3/U]C5U;@F[_RW-2[-$9D];3_/\MN] \[8P0MW2D4RPRYW MAZWO]#CEHQZ
M3.2'%[:FL-&EUNX.$!FA=DF7VR.WA^0>X'Z5.D1G'</RZJ<\OUS*!MO8!:?<
MJ\E,DSV<Y,&1\,V#QH:HO!I@Y16&(#R>*6I"68857>DYA8H,G'4,P4UNA*K>
M/\G5-F4-#CYE%Y]BX0OU*%:L^FS<W5G@8R#I+["'R^8O,Y>7",;\+$8L>P-&
M6[[.KQH]8R7MXKNZ5<OW"&)K&[U_NBC5.[L[T'.%8<!P;*29,9:"7SVP(<QD
MF@LVQ+*%Q1XZ3+0"A/T0&Y94&R)ZYIW+0S:+L<R)$.>1 6.C(%N +[SB[-YP
MH".8)FIIN.NAFKBM E'%NU-TRG7'BZ[A .'U8E8FOT?W _,3-CG)OZ<N4P';
M5D'R*RXF(0OOL93Q5=04?J\-4H/D!"IN)I[YT7Q5+Y?\HC*5:%"O7,_7QBM8
MO/,$&F@[GAM^,@/_!.+;R<R_#VIQ*C)2GA78PR3Q;UJMH%7#K\\7@L4"<PN6
M8]0SX,G,O+RD<""8D0ISAY4*-@&HO#8OD'^7R]5JK1:AD1';S*V38<&3.@B"
MH)Z9G8!C*Q0PTGVZ\8_U0_-5Y_IO_,L-$HFU;HRX>="<0^5+IY%W>/X9'ME+
M;^D(AUD79APK>B"(@!$G \K)/8(A_X> T"T@XHCW2S:K:W/Z,35[!^(2E'+Y
M9L>S.J\F*Z5)KF8ZN>:/R^=X[QN0E;GI>E=7_).DH W^U*(DI!<,1^"^KCP7
MM@V!^,L:T;QQT3N[9*\A$(O';7 -63YI$T61&"P^CD[O5A7GB*')&>Q?F$M.
M3\N;6WU@;7/9^UQ[,EM;>]:X5N;FX<?MB3L:N8>Y ^UO"<\ZU_@\NNX$ ' S
M,_!!D/!B]$^R-:O*U#:\XJPE(9IV_:VDR54N*Z\I(1&KS?4_202BEIOL5I>;
MM:1A"*U;:B?WG/LP7B@+;[W0;"8!(39=@6P]4K_YAK<2J?.5I6]Q.5'H\J'(
MRXE"EQ>]\>5$ZW%S8QQ S(^@R]T0<W  V9N&L$_+%%VXT2D<? AS3%8B6)83
M"\]@GL."D][%5<&=6DM#<T9O$RH#=07\!@+?\&"YB+$0@96#S81[;L@P4]\O
M/Y]0"?^9R3H 59IF) P+CR&&GRPE$-1B'0SX[HZ,V_ JGE;'TEB;!.51I(()
M0D.<E2AU.1/&/OF^)[7MP/DB(EX.:.7VH-KI8!3]GNWNX"4G)+CC)"Y2$^4@
M%]OWDR7P#$C?=X+<138NYS/Q3#Y+1H$O.\ $B5>L;&#>7U0QB^LO.-,-U^8P
M$=,8."[H4)_,%X_&<67:W=G#6GQ%.IJU$P_DH_TXH9:'QF$\F\O%L])3(Z,S
M8=TS6()Y@'0Y2"25>-\ HFGPB X,%P3JC&(@D-2 4+L[IZZ>) $N=1](@$F2
MH+="@WN'A0_O#+7>#!W.^C;T$4/V;!-LU?2(@3T0B0OHPL:,:P:X_?-]X24E
M&G5Z)G.<W1V5.H9#AJYA&@\8]$60][8)2SP9,:/;PP07!8<-3<2 XX3VKJY+
M%_L+,YZ.KWE[#$?X!(@(\M4/*.L4R-?O Z] RX"40%6-Z2(5ALV"2W\H9M1P
M)/@<(#J;C6&!>\A=BG\-K@W[WH\*.![_PI0!%THW%J@A,FES]'![U(V:R>Z.
MB,QYY'6\2OO[(,/GXX*U!PRPW/.BO9@4I"8(E3XA*CA6Q%813Z9'LA0A3;&@
MIF/[F<.I*N#\$=?=G6DS3"""V&%.""<&8H6'2?"RH;@W+3&;@[CL"[#/I+"$
M"2Y- 8X,$X^%#0PNHM8UIO(A!6.8%KIZZ!%U7ED\XD2H9Z _2Z,!4X ,2'HY
MGI&DN"1)3V,@'W@H>*3#Y;!KBW,R82)Z@C/#@+.Y$PX:'2[)/SQ669!895Y.
M%I.Y=T-P>PG^1@4?>N!]Z5V4\%EVU@EV <YFJC3>D5WW=DPSJNO,T;@Q"!T%
MV=UY3)R!$9@6%\EN!FH=ZN],U08%!EO>#0&AX#HC>&EP@M<(<"92M.J$3.\Z
M#P;J#$%HQ*7(F)L5#-;]^[60028:+8=4QSU#Q?5!EI)R'/^K> (-G](>*+!]
MY2'G6(SEWSV&,N@?G(G[61Q/K(*K)@ VX@^HAC'[.!*P<L'VG2*23DI*DEQ:
MH=QXBX(11L97/3699= WY!/-YKZN>_'.O!U4%]UP--/&*WIQ]8#-,.B/VT.A
M%G05OB9GIA A7Y#1F\#E*[#4@3LTITDH;NID7@3GM$*XKD*89PQ\-Y1Y9XPZ
MH0[3\>H8S,:Y9#CPS3QGX(XX ,(OQ@2&A)S)Q;7-<V)MK#@5BQ*\=@(=6<E'
M\!OZ,-L.M_O36B(<;'?'J^\,JDXR>W1_3]F/+DCTUL,GY4:=S+G98I5%BZRR
M<,U+U%&DW1U1H.@=[1-+''%F&)ATY*WT%C-$Z:6/0#!P'$;A<T//>80";ZQU
MF57;H'2[=ARXC%Z31U- S>:@0^!\^6L"V",#Y5Y$W@ #U?$NA)Q1D8AR*C&7
M:IGXCM+T)*I/?&PGZ!^NYQ)/.7H W%_.!8T#[F+)F#Y'\7F/0C>\&C#8#-@F
MN(@4)J?"L//B,8)9P1QU)O"TAR[I,@O\:E.$%#3#]<]9\NESJHM *?JL6]7F
MQQ:$#0=G7H"!L&AY-)VUJ>,U#;\Z'F^"A7[CB]'?)-7KE'4]EI][^0$$X00^
M%L6?.ZJPT8L>]/6OI=A"E7Y(F%ZYD'[]1?0M!>N=%1(NYXU"T_ACP^5>OFP$
MUYUY-TVL>YF/_,??+7D+SQ7C@T\6P1WF-TV!RFPC]U8E;:LYO\FYXIXQDJMK
M7X'S&(< 4TJ\G_YB5,XIV:S,QK*4D&\T\#<Q:IKLN?U-SN=4G)$B?JY0!-MT
M,A>8G1D\^ER&OB>N*:_/-65K7 OV&X_QC>S- G[>#\;LK\/)#Z&"Z1?4':]_
M2=5+>)U^8U[/0JC/X/6[U]K,5I5V8XB6;1A#9)%)'8E 18*+5*A+O7M<][#:
M0A<[<=CE^5O7NOA%7X(_Z3L-4[[^,<TGO<OM'[Q9)R6O')%S+TY<P(&"F,@K
MY>F]N5I8*V.N->4H]W.--&^L./_SKM[LCPC^F$V!E#A5#2WXQ5>D4,-&"LAS
M:?N@EZ@F^5\M*7CMG$CH0KY6_7.CU+YL5C_J+P@]FM\)_<B.'PR;Q;^F)]Y"
MH<>HX\OQJ&.1^M"<>)DWW8M)>U>N^8DW!S##Z)[WNQ4JZU&S$P0K1332;X!1
MP:&%&3X!CP[=GLW!$NNO'-A^KT?UUJJJ7.$) 3!<>S[%E(BUL4 <L'UF0H/A
MUOI-:-"4LN\1D2:#P5%<XK#H:<G'=HA;F\#+XTZS&QM7K,Z;PSK4X-G@I[*2
MVVQ\ W^0J #N)JA;+O@YHJ>C&IF-XG R*2S\YM1F#@>&R9;.;13EE),BUYA>
M.;6[U-J"X#RWEGJC]]K-)N;'O(Z-8KEGL$XH''\N+A/FQRECA;9O\VK>Y;G>
M4V[0>4.V%*#?UBGV3:_IOA.Y[$)&#ZMLTR-ZTXKFL'*_:<WR6OQ.J;:.OPY]
MG.JY?;,X3[06<P/7?JR/CTB](C[<2(<G-Z($3-R<ZB$K^K&O8_GVJG8Z>BA]
M'S_D3^X/&\U.>:Q>W_TLIP_:=K6B#92L\:?EIAL]]3JKW?:M/Z7>GZU\0QH]
MR':YWARE\JG\J=$ZOTW_^O;KP.YWU<[!^/OX6C[]+I_;]9IZ:=6OSK^WQWKC
MH7*?U:0Z4]IN.:-5E,K)C^'GBR]G^9;1L<N36D[Z^I=R3G^ICFK__#GNVZUV
M]JO]\^'+Y=7AO?+Y0>[9#^WKTCFM_&R7^75O\NV,]4:CNY3RY>2A\LV6#?W*
MT6Y[7ZC12WW/J:U*[2#3_7KHL-'PX;I9^]*ZZC4O8%#%/&A?:UKCHM&^9%\U
M76H<ZLT[L_S5RM=R5_G^E3Q6+H?I[[=6_L=(40?#!K^X^W%K';+:Y4\]>Z"/
MP6.LG_RBU</+RDFW>M!-731UK?7S+UEN*G>WTN#K[?#RO->1)C_:S89]R2K?
M;].5*R=?R?TX*.4['35?.KGH_[IT/GGL^']02P,$%     @ ]9'F5-JWC6H;
M0@  \F8! !L   !E83$V,C4U,65X,3 M,5]C<F5A=&EV92YH=&WM?7E3&UF6
M[_^*T'?(Y]?5@5XD&+Q4MUUN(@3(97HP,(#+4S$Q,9&2KE"V4YFJS!18_>G?
MV>Z6BQ!5@.TR'3-5A93*NYU[]O,[;]Y=O#_:[7;>O!OT#^#? ?[OS<7AQ=%@
M]\U3_C=\^U2^?K-W<O!K<'[QZ]'@'T\F65J^#G:VYV5P$<]4$1RKZ^ LFT5I
MR!^$P;G*X\D3^"'\]/2VO_LIF$7Y99R^#O#1[9^"4GTN-Z,DOH2/\OAR6C[9
M?;.W._@\C8=Q"2_<VGGS= ^F?7H? _YK493Q9/ED]Z_IL)C_=-^C' \.+]X-
MSH*+=X?GP?E@_\/9X<6OP?$)?C+0'QP.SH.W\-''=X?[[[H=_UGX[\%_#<[V
M#\_[>T>#X%W_ET&P-Q@<!V>#GP_/+P9G@X/@(PQ2?6'_^ !^N/^N?_SS(-@_
M>?_^\/S\\.0XJ _M?OD6?H>4T;\8=#N'.,C18?]X?Q!\.(6O^\<XE_>G%_CL
MV[.3]S*)LSY]\N'X8%![>W__ E^[\^KY\S#HP]_O!_#80;"!S_TU&?^VR'[R
M'_]K3A_V0EQ#V.WT]_=/S@X.CW\^^C4,WO=Q^RY@"^"M;VGUL*+SDR-:[>#T
M(CC]<';^H7]\$5R<T(3AJ?V+0]@U;ZZT1)C*Q8I9G[GO@GG !OS2/SRB<_#W
M(<2'8;OZ ;S_^!Q^C=_@/,\_[/T3QH<7A#2&-XFSP7]^.#RC:9SC)C5, H\1
M7TQ[@"?1[=!I]T]/CP[W:2JT%/=W1_V/YUL5DL/W5%X/9_Z!7D!G*T0VX'FX
M/\4MA^T^/1H<_#R@V>R?'!\/:(UZ-L'>R7$_>'MX,(#'SWZ6&7\XIET\H2MP
M= (;2"^%E^P!D7W8?^=,9^N;OO CE98J)T:&UXD([&3_/Y" X K"KG[LGP%E
M7#P$9X,YZ+7>VV!FO6]/X(SES?1 F4=I,<GRV>M@,9^K?!05BO?E;-#'>]CM
MP'\<T9F'0$S[6SQ-?-%]S[9" A=$_?N#HZ/ST_X^,)A_/-E^0G^?]@\.]-^W
MGLAU/"ZG^.CV#S\%PRP?JWQSE"5)-"\4S$7^ZPF)Z3<79WJ *Y67\2A*]*3+
M;/Y$1/F;BP/]E+S\Y?8/E<W'^6U.HEF<+%_?-$-ZMHC_K7A!3W8_1CD<6QF<
M3Z-<%?#Z<.?5B_#%JY?F7"X.5LVE6:C?V?0.T[B,HR08? 9ZB@L5'$0E?-E?
M7 +-!SM_"X-GV\^>N7.%?YS=;H,-<32MM&%USN/W/]@=;F51+/3^_7.1JN#Y
M]JK=>TIW9/>A;N2]<$3Y,$['BEX:IT]V2<*MY-3=SD8Y55I#>?-!WY$W3S_L
M:@T%E@&G/(EA?N4T*D/8[CRXBA+8X5R-5'REQC#/))X79:ZB6;"?S6:+%,BB
MC+,4EG!TM!_ +^*R"**B@#D70670=UD"[,,=L]N)BP 6$I<)OGTQS]( ?P/;
M.8/7I..@6 S_I48ED!Q]D<2SN.01 WA6Z3N$C^+WHRP=Q_SU5.4J3J,)O"LH
M5(G+*:=A$)7P\#(H8=_Q#3!C>@0T(O\"5B??>&V]_<,Y\!OG>0S_A"F_?+V]
M'<RW9EO!!I[YKUG^*=B/2QZ^AT^_5<-\$>5+/>[?:T=U 7L!Z\!%U<8,@^&B
M#-*LQ,7#J>!*0AP8MJT8Y?%0T2GBS.:+?#0%\15,\@P.#QXNX4B#,P7T5<9(
M@X?I: OV)W@?IZDJLC+J=D99/L]R'KLR+3C^.6RD/YO%G%:M&6Y0$ L.L@D=
MCOSDKWF!CQ=P6+,9O+@HL]&G,)A'FMS^LKVUO1/,\=SP][4=V>??G>/OO!/8
MB J78*(Q7IH9T!<1PP+N#.Y.TT408>&^#93.*5"G?N Z*I!:@>'07A8+_! &
M.8?!<'MVME[Q.H' \"9%<8K? 3T&?9C"&'Z&QW"F"J!?^.,HBU+Z!!Y:Y$@3
M_<M<*9QM&(SID8AVKDHAS^K[D2L@>OO["H4L:9BA*J^52MV#X+W@6\G4BU04
MX-V-R@Q&)*(JL\I.1+@<NIW=3L[+*9Q;:P_;'%)PJHE/OX,76%M: )N&# 19
M HR\_+;UZ&:6O;WU$IDVG)LA'3RP+9G*A]T#-8E39F+T!=BN(%]2_"!*DF5P
M BP0=N^>]Z9YUE_%?CWS]TMS9/KT3[ I_$]\]2WF$/5J^]'MP%5T!/V6E5UR
M1XU,(,VL #D_APN-VLP8V4;IWOI9M 0> O\:JQ"OZ?4T2Q0)_!19=UF1K#G]
M&X4T3$-D+(W9*$<=V3E4(+$4/5J5?#BGL4I ;"%OREQ6ABN*@O$"K@?H!*,%
MKF 2C0I0%Q+4"N9+FL;IP5OZ Z4$WR)\I]J<17$2;, #\I]164:C*?+2GMZK
MXPQ48-HY,_.8N2G:A[" % 8>!\PQ0UJ0S!4^A2>C$0C3<92.X%RNXW)*/TWY
MI;GZ;0'\#L<KK*X2L 2AY;_<F/:J$K@^(U]\?8119(HJRI,8#@">W8A[07F=
M!1O/0/NZR*-QG%["[BY9W=J(\6N<V6(VY!]XSX#(!N6FP+_QJ?,2?A3E*,1*
M4.%(U)X"26=CDL5CY&2\?'-W-\8]G )K9SU8:9)DU_"^;@=?B'(!![6*'<P+
M":*(XK$GKT U2!*]Q?1%= D"\!)?8$[H-,<=0A4('_!E?5#,U0CUW;$^R&@^
M3T"?'29P1 W'#91R'2-IDE, -R</1E$QA8VU*LU4@;@;Y]%UBO0<!1^ W&&$
M<Y:2PRC]%"S21!4L,?'G](=9[SS/1FJ\@&',]$#M</=OU(,[ GL6Q"N7T$"P
M6_ 9//AI,X/[#A<K:2)JWM>A(4K8]323[>YV\*K-U!C^&R=S"<(;-E0INCNL
M/93+.;W0?@=? 9U'>?QONLITH_ ]35MLA\7)EGA1"J0Q)#CX#1+TI= .$$RF
M=7XXDGS90!ZH&3OO1*8QGRX+M&439 )YCII9[G.Z"F=9@.1-W%<#QS2<$Y0T
MW!;A$14"BZZ E]!9&/73&"KZ47S9$/4R30%TE)-%D@B7C4=3)!/5L+KF^9M]
MT0N8$)T"XTD2YJ77FC'D>'+/>_X5E[7P3=0S(#[71C)QX; Z?W!07DY!."##
MUPN4$9P-A[U:)"5. &6)[&S!+!W,#YJSS*H$0DH<YK3&C@OE3J,KEBIJ,D'[
M 'X,EPAXE;"R;%$:2FM]OTRN,@)R=_B_60:D$@"IP0QE%YSKR.]T97+EI4CR
M%[X^[IXB'SE(IY1,"S#)09P !Y@2]ZSP[+81]%N['<UHBP6<KMESGH$_I&:Q
M)&7)ML+S0/.J^0X+=64IT-9.+]A;@+1 %@?$A<^1+V%>ZK&['9:!6XY@<W_B
MB#1@/,!X:=@QOHO9S12V_CPJ%R!;@0.<PXG@=YH;T1_F&H%)@I.$\T%&7.#!
MT7K!^J*#,38Z[%H0+<HI,,I_PZ[!ZPP+ 2F01->X?A#8>!*C)(.=_<FH7\#!
MKV(P]W#FH?D4CDE=L?.#/2NC!#CB1-PGH3.W;H<GYW&P,5IV=+F&MYT9:$5X
M;_3^ I$O456;9C,E&QN:[Z8J 3T-=,O->1*-S/?=CCR09NDF' P:(WBC9_,D
M6RK]&/E2TJ6Q(D'UBE!( C47/-&B!'DLSAL6R3A%%'8B$C1S#H9 OG!B22;N
M)9PQTRTL=:0Y O[D,H-M35'S@)_)SH Q763P8Q0:+&A5 K_*LS0> 6]%Z]4(
M\6)9E K,UHTX'24+NOYX/)ZD+TAFU8_(H9_ )9]+E:J<1 P24C8']H[O7+ 2
M,0(]'C8_)P\6W3^@TKLS7'Z7^? UF#!F]/^SN1F\C54R?AV<1I?J)QCBMX4"
M 08S^2DXF1-%O,:I:*UH<U-[G@\.?]%SYQEMEMD<?O=L7NHY;@ZS$@[@=? C
M?B8Q#?W9'M#]IV!GZR4LH,B2> SS^AV[47</F]%I/ML-TR&7MKMXO>R?@@M0
MJEX'_3P:QJ.?@N-HIGAK0)^#I>^X/WJJ?X7?X):^>0I[TK ]PUQ%GS;9W'H-
M)AQNM#O%'QNFB-OH;HASZ"X->4.Z<\,Y\V%]SX0^;++5R51A,QUYBF,0H( U
MSE#D,YYK;5%78(T*_Y>=K1<[-WE$JV9EPY2,3?G(I$;V[/;%>.MV/ ]4<#AQ
MW1TF1,7>5%26TTR44'3 @\D:@UQDS9R<J70\_#&IIZ$6EJ!9H,%7+@JR>2*R
MK4NVAN"]I$HY*K V>]%X3HS/QU<-R:I(ZYZ>*"E(U3!62;O/AR08.7V&2U;1
M2)>*-$G5;%RM+L2N<>$9-CBP!(58G:'P$[RR5<,=JY*<1:CBDJ.%/0J9.&C$
MQT"NFD42O?[ST?'.]G.46>O,8O,YB;<GN\>J#(YY1_]AJ'JCW^U\#O9ZP6:P
MT0\^!_L]I.H[GNR/VRU3?;*[]^7WY6O@,V\QC+C(YQE;PNP=0U%]F=T?(>^T
M3/&>2+9UM(U^+_C'&O:^>%+AO^8BX#1#<=A97#"/&RK<.,?-(L:OD;37R)XU
M#V/O _(N^P P:6-R1G7?W1U+QZ_F,/;P,- /:YP9K]F+#.?SR\?^:<!!>\^;
M',1@*XUCD&9@!,V1@8^UET)['FYT5YH3:G8YH7,!]-*I=?A[/O=NIRE*^VPC
M8M\SO(S\L^@@H)@MR640GZXS#$7=QK.5PS3&@IU10!:FE9>:[ !R.X%QB%_
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M%2B6Y 5"P/](3'!"&,"*'GVUQ35$UV>5*/ 3'$TC;)MK:3MUFQ0(-^?0#PB
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M,3;%K!*4'#S]FK(9X=[#9&\Z&0XJ&C H]B_<:(S;\J2JGNE@F#03SLK):$)
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M!4#SJ(IX8Z='Z2D4YA(L90G_*TQ)YCH\D]+UO_*_&D!B!;'-Z0-5J5!5MDN
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MZNN ^I3D@TB>G>\P0%,6%(VFDXPRXC'S;-2@'QLJZTO&93>.OMA.<$9S!/!
M)W:JP4B=,F9L>T88_$NV,:)+?DL9U=3O\3Z8P@\S:]M_INLYB_DUO>M ;ED2
MK8.,NQK$4)Y(8S'7%KF3MFE"MC=<VP)1UKZ?ZE:<6EV$4YTFY[Y%3= (O9!T
MJ@TT*3.0LJE0#_RQ[!=Y(6(*9:F"EP<G2]?;E^J?5=N(=Z9MDD@O)OV[XBGD
M^@R$:C8.V[8"I,OM=Z7S0=5BHUHE*W@4K#9ZDZ9F #WEX-(EA?\B4A&C%)M7
M@&Z@;M'*K@KU,K%R@!HPNRJ S*/[X/AG&2+B=O:UB)7?:&^I/1L/AS76CIV-
M_'*UK("8R*1FOYU%N<,X@D6>H<UMW1S[V]5+>54@X)HOLBPT56,4#V%^<<S/
M]9ZM.R%   4;SYVI25:5K^W>6D\2-JRHRT3OMI3:>T_B[_W90^J%V$+2-DLZ
M->,R-"'<^C(U"C!4%=VF88'*J("?5.N!77RCP!+\>+V2HE?1-1?%VOS(&;4_
M8'KH(<H4_OJ=ERG\];%,X9OB:0L$^]B<>56F<&$+*S5C*.7P"P4J:)2 A$,X
MG*5U,)D&,G65S3!E) JF.VYVA6TUK>;3"C-)Q7E( R_US,-H)DZDJZBUKK!D
MFAW59/$&)@C+V6Z#B7$;Q&+:"E98UL8TC@:A-7!2&U'.T"9*&EQ;AH2"9#<D
MM@ #-?KU)]I%7K%NTGJ=Q'M;=KI9YNR$D;8P+6D]CXLQT$:45Z]LQ(C*Q.IB
MA>X8'.8I6KG&0]=5]V:@*[(P6AG*8;9[ATQTY[8LM>X0-W$NMJ$?=9T- *\I
MJ_(ZS:".BOE)WL<-P9 @X#"ZXBR,#4K'E@?%Q%P9U;I4V"O[;UV,@0AI,?PE
M@*^,2Y9!W"]$B/(%_;<1I*)(#IO4H)Q4238_,U&W:ZF=95,V&E/N+V& 1OW4
M9AFTTZ,NEZFH>PMFJCVLF")0F$)E(:GJN4)\.)5P3.H%)=KM<*DRYQ]9W$91
M5K$39"N>W*=K]00NC@.!J6&K[O! 2^NJ(_Q;.HF3QK?^1!.%()J2DD4X.HL9
MW0HC*R3N1$%,Z8TJ-DQ04ZF@CQI2S%_:_5+T0V\BPABK]*L/2XX58380@=I
M 5WJ >>HW;-$^Q:8&9\)BC1"76P6TTVZH+1(3KI&0K3-= >"G)"KV9P=<;:
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M=8!.<$PBF7)@/5]F-JL5A-2$#I2=Y3)64_?RKF@_3FL]/=.;-F>MIF6"IA2
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MCDA*OZ=#*:$$7O!0Y44P2<O)8E91PHZK[8.;8I'%*J/B/!D6.E/;[)(7BUO
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M=F#%+TI<MMJ@%J77] .]+<!W0;Y7FTH^6!H+M;QEKC8>Z-L5U%,=>ZJRRR
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M6>27V_SG>R<'_T!^?O[+Q;NCW?\/4$L! A0#%     @ ]9'F5)"O$ C# P
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M,#(R,#8S,%]P<F4N>&UL4$L! A0#%     @ ]9'F5*_3,;HW%P  G(D  !@
M             ( !H2$  &5A,38R-34Q+3AK7V-R96%T:79E+FAT;5!+ 0(4
M Q0    ( /61YE3:MXUJ&T(  /)F 0 ;              "  0XY  !E83$V
M,C4U,65X,3 M,5]C<F5A=&EV92YH=&U02P$"% ,4    " #UD>94GJ=D;8!)
M  "AB@$ &P              @ %B>P  96$Q-C(U-3%E>#$P+3)?8W)E871I
M=F4N:'1M4$L! A0#%     @ ]9'F5%-V(WC/20  7) ! !L
M ( !&\4  &5A,38R-34Q97@Q,"TS7V-R96%T:79E+FAT;5!+!08     "  (
+ "D"   C#P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
